Sanjari Moghaddam Ali, Nazarzadeh Milad, Noroozi Rezvan, Darvish Hossein, Mosavi Jarrahi Alireza
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, IR Iran.
Iran J Cancer Prev. 2016 Feb 23;9(1):e3467. doi: 10.17795/ijcp-3467. eCollection 2016 Feb.
Known polymorphisms of DNA repair genes can be associated with the risk of many types of cancer. There is no consensus regarding association between XRCC1 and OGG1 with breast cancer (BC).
The aim of this study is to collect relevant published studies systematically.
Sixty-two publications were identified through searching PubMed, PubMed Central, ISI web of knowledge, and reference list of related articles.
We performed a systematic review according MOOSE guideline criteria. All longitudinal cohort and case-control studies investigating association of any type and grade of breast cancer with XRCC1 and OGG1 gene and their polymorphisms were eligible for initial inclusion.
Two authors screened titles and abstracts and extracted all needed information from eligible studies. Four research methodological components causing bias for the association between gene polymorphisms and breast cancer risk, including source of controls sampling, population ethnicity, sample size of studies and menopausal status of cases and controls was used for assessment of quality of studies.
A total of 14,793 breast cancer cases and 15,409 controls were included in assessment of XRCC1 Arg194Trp. Four studies showed significant association and one study showed protective effect of XRCC1 Arg194Trp and BC. A total of 7,716 cases and 7,370 controls were included for XRCC1 Arg280His. Only one study showed significant association of XRCC1 Arg280His and breast cancer (OR = 1.82 (1.06 - 3.15). A total of 27,167 cases and 31,998 controls were included to estimate association between XRCC1 Arg399Gln polymorphism and breast cancer. Seven studies showed significant association and one showed protective effect of XRCC1 Arg399Gln and BC. A total of 9,417 cases and 11,087 controls were included for OGG1 Ser326Cys. Among studies focused on OGG1 Ser326Cys, none showed significant association with breast cancer.
Systematic search of major databases identify many studies addressing the relationship between BC and susceptible alleles in the base excision repair genes and the fact that there are many variations in the magnitude of association depending on inheritance model and the population of the study.
已知DNA修复基因的多态性可能与多种癌症的风险相关。关于X射线修复交叉互补基因1(XRCC1)和8-氧鸟嘌呤DNA糖基化酶1(OGG1)与乳腺癌(BC)之间的关联尚无共识。
本研究的目的是系统收集相关的已发表研究。
通过检索PubMed、PubMed Central、科学网(ISI)以及相关文章的参考文献列表,共识别出62篇出版物。
我们根据MOOSE指南标准进行了系统评价。所有调查任何类型和分级的乳腺癌与XRCC1和OGG1基因及其多态性之间关联的纵向队列研究和病例对照研究均符合初步纳入标准。
两位作者筛选了标题和摘要,并从符合条件的研究中提取了所有所需信息。用于评估研究质量的四个导致基因多态性与乳腺癌风险之间关联产生偏差的研究方法学因素,包括对照抽样来源、人群种族、研究样本量以及病例和对照的绝经状态。
在对XRCC1基因第194位密码子精氨酸突变为色氨酸(Arg194Trp)的评估中,共纳入了14793例乳腺癌病例和15409例对照。四项研究显示出显著关联,一项研究显示XRCC1 Arg194Trp对乳腺癌有保护作用。在对XRCC1基因第280位密码子精氨酸突变为组氨酸(Arg280His)的评估中,共纳入了7716例病例和7370例对照。只有一项研究显示XRCC1 Arg280His与乳腺癌有显著关联(比值比(OR)=1.82(1.06 - 3.15))。在对XRCC1基因第399位密码子精氨酸突变为谷氨酰胺(Arg399Gln)多态性与乳腺癌关联的评估中,共纳入了27167例病例和31998例对照。七项研究显示出显著关联,一项研究显示XRCC1 Arg399Gln对乳腺癌有保护作用。在对OGG1基因第326位密码子丝氨酸突变为半胱氨酸(Ser326Cys)的评估中,共纳入了9417例病例和11087例对照。在聚焦于OGG1 Ser326Cys的研究中,没有一项显示与乳腺癌有显著关联。
对主要数据库的系统检索发现了许多探讨乳腺癌与碱基切除修复基因中易感等位基因之间关系的研究,并且根据遗传模型和研究人群的不同,关联程度存在许多差异。